Breaking News Instant updates and real-time market news.

WFM

Bought by AMZN

$42.68

9.62 (29.10%)

, AAPL

Apple

$142.27

-2.02 (-1.40%)

08:55
06/19/17
06/19
08:55
06/19/17
08:55

Notable open interest changes for June 19th

Friday's total option volume of 19.2 million contracts resulted in net open interest growth of 3.50 million calls and 3.91 million puts. Whole Foods (WFM), Apple (AAPL), Alibaba (BABA) and Micron (MU) saw the greatest growth. Top five new positions opened include 58k Whole Foods (WFM) Jan-18 42 calls, 50k Kinross Gold (KGC) Jul-17 4 puts, 47k Whole Foods (WFM) Aug-17 42 calls, 35k Whole Foods (WFM) Nov-17 42 calls and 28k Potash (POT) Sep-17 17 puts.

WFM

Bought by AMZN

$42.68

9.62 (29.10%)

AAPL

Apple

$142.27

-2.02 (-1.40%)

BABA

Alibaba

$134.87

-0.21 (-0.16%)

MU

Micron

$29.86

-0.7 (-2.29%)

  • 22

    Jun

  • 26

    Jun

  • 29

    Jun

  • 29

    Aug

WFM Bought by AMZN
$42.68

9.62 (29.10%)

06/19/17
KEYB
06/19/17
NO CHANGE
KEYB
Wal-Mart outlook still positive after Whole Foods deal, says KeyBanc
KeyBanc says that Wal-Mart (WMT) stock should be bought in the wake of the Whole Foods (WFM) deal, as the firm remains confident in Wal-Mart's ability to achieve 5%-9% earnings growth in fiscal 2018. The analyst says that the market shares of both Amazon and Wal-Mart have room to grow, and it believes that Amazon will continue to skew towards upper class Americans in the wake of the Whole Foods deal. The firm keeps a $90 price target and an Outperform rating on Wal-Mart.
06/19/17
PIVT
06/19/17
UPGRADE
Target $42
PIVT
Hold
Whole Foods upgraded to Hold from Sell at Pivotal Research
06/19/17
RBCM
06/19/17
NO CHANGE
RBCM
Wal-Mart, Costco could be hurt by Whole Foods deal, says RBC Capital
RBC Capital analyst Scot Ciccarelli warns that Wal-Mart (WMT) and Costco (COST) could be hurt by the Whole Foods deal. The analyst says that "combining Whole Foods' high-end reputation with a logistics juggernaut like Amazon is clearly a danger" to Costco and Walmart. He thinks that Whole Foods could extend the hours in which it allows customers to buy products online and pick them up in stores, and he thinks that food delivery could become much more popular in the wake of the deal. He notes that Wal-Mart has spent a great deal of time and money on "improving its fresh and omni-channel offerings." The analyst says that Costco will be more protected due to what he sees as its "differentiated retail experience."
06/19/17
RBCM
06/19/17
NO CHANGE
RBCM
Concerns over dollar stores 'way overdone,' says RBC Capital
RBC Capital analyst Scot Ciccarelli says that concerns about the dollar stores in the wake of the Whole Foods deal were "way overdone,." The analyst thinks that they compete in "a very different segment and customer base" than Whole Foods. Publicly traded dollar stores include Family Dollar (FDO) and Dollar General (DG).
AAPL Apple
$142.27

-2.02 (-1.40%)

06/15/17
UBSW
06/15/17
NO CHANGE
Target $35
UBSW
Buy
Jabil Circuit price target raised to $35 from $30 at UBS
UBS analyst Steven Milunovich raised his price target on Jabil Circuit (JBL) to $35 from $30 following solid Q3 results and its positive 2018 outlook. The analyst said the company still has a 24% revenue dependence on Apple (AAPL). Based on its guidance for 2018, it must have reasonable confidence in the iPhone 8 cycle, said Milunovich, who reiterated his Buy rating on Jabil shares.
06/15/17
SBSH
06/15/17
NO CHANGE
Target $163
SBSH
Buy
Citi on Apple buying athenahealth? 'Never say never'
After CNBC reported that Apple (AAPL) is working on making the iPhone into a centralized management of patient health data, Citi analyst Garen Sarafian says athenahealth (ATHN) is a "well-suited candidate" to help. In a research note titled "Apple For athenahealth? Never Say Never," the analyst argues that athenahealth would accelerate Apple's efforts for interoperability. He believes Apple "would be one of few homes" that CEO Jonathan Bush would consider. Sarafian has a Buy rating on athenahealth with a $163 price target. The digital provider of medical records is down 42c to $142.34 in midday trading.
06/16/17
MSCO
06/16/17
NO CHANGE
Target $177
MSCO
Overweight
Recent Apple pullback largely due to overall tech weakness, says Morgan Stanley
Morgan Stanley analyst Katy Huberty believes the recent pullback in Apple shares, which are down 7% in the last week, is largely a result of overall weakness in the tech sector and not a change in investor sentiment towards the stock. She notes that Apple shares have risen an average of 18% in the 3 months prior to iPhone announcements over the last ten years, which she believes suggests the recent weakness creates an attractive opportunity to buy the stock. Huberyty keeps an Overweight rating and $177 price target on Apple.
06/19/17
MAXM
06/19/17
NO CHANGE
Target $180
MAXM
Buy
Apple price target raised to $180 after international survey at Maxim
Maxim analyst Nehal Chokshi raised his price target on Apple to $180 from $171 after the firm's May survey pointed to significant pent-up demand from new and existing iPhone users in China. Choksi raised his FY18 revenue and earnings estimates for Apple after increasing his iPhone unit forecast by 19% and his average selling price view by 4%. He keeps a Buy rating on Apple shares.
BABA Alibaba
$134.87

-0.21 (-0.16%)

06/13/17
RAJA
06/13/17
NO CHANGE
Target $190
RAJA
Strong Buy
Alibaba price target to $190, remains a Top Large Cap pick at Raymond James
Raymond James analyst Aaron Kessler raised Alibaba's price target to $190 from $160 and raised estimates following last week's analyst day and guidance saying he has increased confidence in the revenue growth outlook for the retail segment. Kessler continues to rate Alibaba a Strong Buy and A Top Large Cap Internet pick given attractive valuation, expectations for continued strong core commerce revenue growth and margins, cloud leadership, and reduced losses on investments.
06/12/17
KEYB
06/12/17
NO CHANGE
KEYB
Alibaba price target raised to $160 from $137 at KeyBanc
After attending Alibaba's Investor Day, KeyBanc says it's more confident that the company's initiatives will enable it to grow its core commerce monetization over the long-term. The firm raised its estimates based on the company's guidance and increased its price target on the name to $160 from $137 while keeping an Overweight rating on the stock.
06/12/17
UBSW
06/12/17
NO CHANGE
Target $175
UBSW
Buy
Alibaba price target raised to $175 from $141 at UBS
UBS analyst Ming Xu raised his price target on Alibaba to $175 from $141 following its second annual investor day. The analyst said the presentation showcased a robust platform for its core commerce operations and the broad scope of its ecosystem on the back of multi-year strategic growth initiatives in the international, logistics, media and entertainment, and cloud segments. Ming reiterated his Buy rating on Alibaba shares.
06/19/17
DBAB
06/19/17
NO CHANGE
Target $158
DBAB
Buy
Alibaba price target lowered to $158 from $161 at Deutsche Bank
Deutsche Bank analyst Alan Hellawell trimmed his price target for Alibaba shares to $158 after reducing his FY19 revenue forecast by 1% to reflect price cuts in AliCloud and his FY18/FY19 non-GAAP net income estimates by 2% due to reinvestment in e-commerce. The analyst views his revised assumptions as "easily achievable" and keeps a Buy rating on Alibaba.
MU Micron
$29.86

-0.7 (-2.29%)

06/13/17
MACQ
06/13/17
NO CHANGE
MACQ
Micron demand to remain healthy, says Macquarie
Macquarie analyst Srini Pajjuri "expects DRAM pricing to remain firm through the end of 2017." The analyst expects "upward pressure" on mobile DRAM prices as China recovers and production of Apple's iPhones accelerates. The analyst expects Micron's cost per bit to drop significantly, and he raised his fiscal 2018 EPS estimate for the company to $5.53 from $5.34. He keeps an Outperform rating on the stock.
06/14/17
FBCO
06/14/17
NO CHANGE
Target $40
FBCO
Outperform
Memory cycle may be plateauing, but not peaking, says Credit Suisse
Credit Suisse analyst John Pitzer said Micron's significant "beat and raises" may be plateauing into the second half of the year, but not peaking, given that he sees the current memory cycle as one that will be "stronger-for-longer." To support that view, Pitzer points to increasing costs of capacity, new applications supporting diversification and demand and the fact that more time would be needed for a cycle-ending supply response. He raised his estimates for Micron and keeps an Outperform rating and $40 price target on the shares.
06/15/17
LOOP
06/15/17
NO CHANGE
Target $40
LOOP
Buy
Micron price target raised to $40 from $35 at Loop Capital
Loop Capital analyst Betsy Van Hees said she believes Micron continues to benefit from being in the "sweet spot" of the memory cycle and she expects favorable dynamics around supply/demand and price increases to keep driving healthy earnings and revenue growth in the second half. Saying she sees no near-term negative catalysts ahead, Van Hees recommends investors keep adding to Micron positons ahead of its Q3 report. She raised her price target on the stock to $40 from $35 and keeps a Buy rating on the name.
06/09/17
NOMU
06/09/17
NO CHANGE
NOMU
Micron has positive read through from Broadcom news, says Nomura Instinet
After meeting with Broadcom's (AVGO) CEO, Nomura analyst Romit Shah thinks that the company tried to buy Toshiba's (TOSBF) NAND flash business. The analyst says that Broadcom's effort should lead investors to question whether Micron (MU) is undervalued. He keeps a $40 price target and Buy rating on the shares.

TODAY'S FREE FLY STORIES

CTIC

CTI BioPharma

16:11
01/21/18
01/21
16:11
01/21/18
16:11
Conference/Events
CTI BioPharma to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ZSAN

Zosano Pharma

$0.45

-0.0387 (-7.92%)

16:00
01/21/18
01/21
16:00
01/21/18
16:00
Conference/Events
Zosano Pharma to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

15:39
01/21/18
01/21
15:39
01/21/18
15:39
Conference/Events
Sanmina to hold a conference call »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

12:05
01/21/18
01/21
12:05
01/21/18
12:05
Periodicals
Amazon automated grocery store opens Monday, Reuters says »

Amazon will open its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 18

    Mar

TWTR

Twitter

$23.66

-0.38 (-1.58%)

09:07
01/21/18
01/21
09:07
01/21/18
09:07
Periodicals
Twitter COO in discussions to become SoFi CEO, WSJ reports »

Twitter's COO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

CLF

Cleveland-Cliffs

$8.49

0.08 (0.95%)

09:02
01/21/18
01/21
09:02
01/21/18
09:02
Hot Stocks
Cleveland-Cliffs addresses ''inaccurate media reports' on Nashwauk property »

Cleveland-Cliffs said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

15:26
01/20/18
01/20
15:26
01/20/18
15:26
Hot Stocks
Opdivo, Yervoy combo demonstrates activity in patients with dMMR, MSI-H mCRC »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

  • 08

    Mar

EXEL

Exelixis

$28.00

0.14 (0.50%)

, RHHBY

Roche

$30.69

0.18 (0.59%)

15:22
01/20/18
01/20
15:22
01/20/18
15:22
Hot Stocks
Exelixis presents updated results from Phase 1b clinical trial in CRC »

Exelixis (EXEL) announced…

EXEL

Exelixis

$28.00

0.14 (0.50%)

RHHBY

Roche

$30.69

0.18 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

  • 08

    Feb

  • 15

    Feb

  • 23

    Feb

ARRY

Array BioPharma

$13.14

0.26 (2.02%)

15:17
01/20/18
01/20
15:17
01/20/18
15:17
Hot Stocks
Array BioPharma updates results from BEACON Phase 3 trial »

Array BioPharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

  • 30

    Jun

SO

Southern Company

$44.44

-0.46 (-1.02%)

15:13
01/20/18
01/20
15:13
01/20/18
15:13
Hot Stocks
Southern Company accelerates restoration efforts in Puerto Rico »

Southern Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$29.43

0.19 (0.65%)

15:10
01/20/18
01/20
15:10
01/20/18
15:10
Hot Stocks
Teck Resources announces Elkview incident »

Teck Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

TWTR

Twitter

$23.66

-0.38 (-1.58%)

14:03
01/20/18
01/20
14:03
01/20/18
14:03
Hot Stocks
Twitter begins notifying users exposed to Russian propaganda during elections »

Twitter, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

, SPX

S&P 500

13:58
01/20/18
01/20
13:58
01/20/18
13:58
Periodicals
Government shuts down on anniversary of Trump presidency, Reuters reports »

President's Trump…

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

1.49 (0.83%)

, NYT

New York Times

$21.90

1.7 (8.42%)

13:48
01/20/18
01/20
13:48
01/20/18
13:48
Periodicals
NY Times stock jumps after Facebook's announcement, Recode reports »

Facebook (FB) CEO Mark…

FB

Facebook

$181.29

1.49 (0.83%)

NYT

New York Times

$21.90

1.7 (8.42%)

NWSA

News Corp.

$17.22

0.21 (1.23%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

WMT

Walmart

$104.59

0.29 (0.28%)

13:36
01/20/18
01/20
13:36
01/20/18
13:36
Periodicals
Still time to shop Walmart shares as company makes changes, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, NFLX

Netflix

$220.46

0.13 (0.06%)

08:59
01/20/18
01/20
08:59
01/20/18
08:59
Periodicals
Netflix among likely candidates for an Apple purchase, Barron's says »

Especially for tech…

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 01

    Feb

BA

Boeing

$337.73

-2.43 (-0.71%)

08:50
01/20/18
01/20
08:50
01/20/18
08:50
Periodicals
Boeing not a sell just yet, Barron's says »

Boeing stock has come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, EADSY

Airbus

$28.43

0.755 (2.73%)

08:24
01/20/18
01/20
08:24
01/20/18
08:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$178.46

-0.8 (-0.45%)

EADSY

Airbus

$28.43

0.755 (2.73%)

BA

Boeing

$337.73

-2.43 (-0.71%)

VZ

Verizon

$51.91

0.36 (0.70%)

NYT

New York Times

$21.90

1.7 (8.42%)

TWX

Time Warner

$93.36

0.39 (0.42%)

DIS

Disney

$110.59

0.17 (0.15%)

TIME

Time Inc.

$18.55

0.05 (0.27%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

BAC

Bank of America

$31.72

0.24 (0.76%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BK

BNY Mellon

$56.61

1.26 (2.28%)

WLKP

Westlake Chemical Partners

$24.45

-0.1 (-0.41%)

MON

Monsanto

$120.66

1.8 (1.51%)

DLTR

Dollar Tree

$114.73

1.83 (1.62%)

CE

Celanese

$112.96

1.93 (1.74%)

LYB

LyondellBasell

$119.92

3.03 (2.59%)

TSE

Trinseo

$79.45

2.2 (2.85%)

EYE

National Vision

$43.13

1.12 (2.67%)

ETFC

E-Trade

$54.28

0.63 (1.17%)

LPLA

LPL Financial

$59.03

0.53 (0.91%)

AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

SCHW

Charles Schwab

$55.48

0.15 (0.27%)

ADS

Alliance Data

$261.82

5.88 (2.30%)

FISV

Fiserv

$138.11

0.17 (0.12%)

FLT

FleetCor

$206.65

3.4 (1.67%)

HAWK

Blackhawk

$45.25

0.1 (0.22%)

MTZ

MasTec

$53.30

1.25 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 25

    Jan

  • 26

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 02

    Feb

  • 06

    Feb

  • 07

    Feb

  • 15

    Feb

  • 16

    Feb

  • 21

    Feb

  • 08

    Mar

  • 18

    Mar

CME

CME Group

$154.28

2.07 (1.36%)

, GS

Goldman Sachs

$256.12

5.15 (2.05%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Bar Association to hold annual meeting »

Derivatives & Futures…

CME

CME Group

$154.28

2.07 (1.36%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BP

BP

$42.40

-0.5 (-1.17%)

C

Citi

$78.30

0.91 (1.18%)

BAC

Bank of America

$31.72

0.24 (0.76%)

CS

Credit Suisse

$19.06

0.13 (0.69%)

CRL

Charles River

$107.89

1.22 (1.14%)

MS

Morgan Stanley

$57.46

1.62 (2.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

  • 24

    Jan

  • 31

    Jan

  • 01

    Feb

  • 15

    Feb

AMGN

Amgen

$189.28

1.69 (0.90%)

, BAYRY

Bayer

$32.05

0.235 (0.74%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2018 ASCO…

AMGN

Amgen

$189.28

1.69 (0.90%)

BAYRY

Bayer

$32.05

0.235 (0.74%)

BLRX

BioLineRx

$1.09

-0.02 (-1.80%)

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

CELG

Celgene

$102.65

0.93 (0.91%)

DNA

Bought by RHHBY

ESALY

Eisai

$56.88

0.115 (0.20%)

EXEL

Exelixis

$28.00

0.14 (0.50%)

HALO

Halozyme

$17.98

0.13 (0.73%)

INCY

Incyte

$93.16

1.24 (1.35%)

IPSEY

Ipsen

$34.65

0.75 (2.21%)

LXRX

Lexicon

$10.44

0.2 (1.95%)

MGNX

MacroGenics

$19.19

0.3 (1.59%)

MRK

Merck

$61.28

0.15 (0.25%)

NVS

Novartis

$86.94

0.53 (0.61%)

SNY

Sanofi

$44.60

0.09 (0.20%)

ONCY

Oncolytics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 02

    Feb

  • 03

    Feb

  • 05

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 02

    Mar

  • 05

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 02

    May

  • 17

    May

  • 28

    May

  • 23

    Oct

WLFC

Willis Lease

$26.66

0.05 (0.19%)

18:59
01/19/18
01/19
18:59
01/19/18
18:59
Hot Stocks
Willis Lease announces $1,000 bonus for employees »

Willis Lease announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPS

Dr Pepper Snapple

$96.35

1.03 (1.08%)

18:13
01/19/18
01/19
18:13
01/19/18
18:13
Hot Stocks
Dr Pepper to become official sponsor of esports team TSM »

Dr Pepper announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$11.70

0.09 (0.78%)

17:53
01/19/18
01/19
17:53
01/19/18
17:53
Hot Stocks
Vintage Capital in standstill pact with Rent-A-Center »

On January 17, Vintage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AR

Antero Resources

$18.74

-0.59 (-3.05%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Recommendations
Antero Resources analyst commentary at MUFG »

Antero Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.21

0.06 (0.16%)

, TWX

Time Warner

$93.36

0.39 (0.42%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Periodicals
AT&T requesting docs from companies in Time Warner deal hearing, Reuters says »

AT&T (T) is…

T

AT&T

$37.21

0.06 (0.16%)

TWX

Time Warner

$93.36

0.39 (0.42%)

VZ

Verizon

$51.91

0.36 (0.70%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

DISH

Dish

$45.26

0.1 (0.22%)

CHTR

Charter

$366.05

0.8 (0.22%)

DIS

Disney

$110.59

0.17 (0.15%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.